|
Volumn 19, Issue 10, 2013, Pages 1207-1208
|
Therapeutically reeducating macrophages to treat GBM
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLZ 945;
COLONY STIMULATING FACTOR RECEPTOR;
GAMMA INTERFERON;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BINDING AFFINITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PROGNOSIS;
CANCER SURVIVAL;
CELL DEATH;
CELL INVASION;
CELL PROLIFERATION;
CELL SURVIVAL;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SPECIFICITY;
GLIOBLASTOMA;
GLIOMA CELL;
HOST CELL;
IMMUNOCOMPETENT CELL;
IMMUNOSUPPRESSIVE TREATMENT;
IN VITRO STUDY;
INFLAMMATION;
LYMPHOCYTE DEPLETION;
METASTASIS;
NONHUMAN;
OVERALL SURVIVAL;
PHENOTYPE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
STROMA;
SURVIVAL FACTOR;
TARGET CELL;
THERAPY EFFECT;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR CELL;
TUMOR GROWTH;
TUMOR INVASION;
TUMOR MICROENVIRONMENT;
TUMOR REGRESSION;
TUMOR VASCULARIZATION;
VASCULARIZATION;
XENOGRAFT;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BRAIN TUMOR;
CYTOLOGY;
MACROPHAGE;
PATHOLOGY;
ANIMALS;
BRAIN NEOPLASMS;
GLIOBLASTOMA;
MACROPHAGES;
RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;
|
EID: 84887430739
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3355 Document Type: Article |
Times cited : (33)
|
References (14)
|